ZJYL:NASDAQJIN MEDICAL INTERNATIONAL LTD. Analysis
Data as of 2026-09-01 - not real-time
$2.32
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Jin Medical International Ltd. is neutral at $2.32, with no clear ordering between short and long averages. It has gained 16.1% over the past 30 days. RSI sits at 42.2, which reads as neutral, and MACD momentum is bearish. Watch $1.53 as support and $3.74 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 11.6 sits below the sector average of 30.4. Revenue is contracting at 9.7% on a 5.9% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 150.3%, a beta of 1.04 and a maximum drawdown of 86.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Valuation screens as undervalued: a P/E of 11.6 sits below the sector average of 30.4. Revenue is contracting at 9.7% on a 5.9% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 150.3%, a beta of 1.04 and a maximum drawdown of 86.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
CHANGZHOU, China, Aug. 5, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. Nasdaq: ZJYL 'Jin Medical', and together...JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial ResultsDetailed price information for Jin Medical International Ltd ZJYL-Q from The Globe and Mail including charting and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 2.92
- MACD momentum is negative
- 30-day price change of +16.1%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 11.6 versus sector average of 30.4
- Trading below the 200-day average of 2.92
- 30-day volatility of 150.3%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 11.6 versus sector average of 30.4
- Revenue contracting at -9.7%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth-9.70%
Profit Margin5.95%
P/E Ratio11.6
ROE4.02%
ROA0.50%
Debt/Equity69.34
P/B Ratio0.6
Op. Cash Flow$-592867
Free Cash Flow$-7487311
Industry P/E30.4
Technical Analysis
TrendNeutral
RSI42.2
Support$1.53
Resistance$3.74
MA 20$2.78
MA 50$2.34
MA 200$2.92
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.04
Volatility150.31%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.